acetaminophen has been researched along with Ovarian Neoplasms in 33 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the basic expression of ABC transporters in an epithelial ovarian cancer cell line, and to investigate whether low concentrations of acetaminophen and ibuprofen inhibited the growth of this cell line in vitro." | 7.81 | Gene expression profile of ABC transporters and cytotoxic effect of ibuprofen and acetaminophen in an epithelial ovarian cancer cell line in vitro. ( Cândido, EB; da Silva Filho, AL; de Melo, FP; Lima, RA; Piedade, JB; Silva, LM; Vidigal, PV, 2015) |
| "Aspirin use was associated with a reduced risk of ovarian cancer (OR = 0." | 6.50 | Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. ( Anton-Culver, H; Bandera, EV; Berchuck, A; Brinton, LA; Chandran, U; Cramer, DW; Doherty, JA; Gayther, SA; Gentry-Maharaj, A; Goode, EL; Goodman, MT; Hogdall, E; Jensen, A; Jordan, SJ; King, MG; Kjær, SK; Lo-Ciganic, WH; Lurie, G; Menon, U; Murphy, MA; Nagle, CM; Ness, RB; Olson, S; Pearce, CL; Pike, MC; Poole, EM; Ramus, SJ; Risch, HA; Rossing, MA; Schildkraut, JM; Terry, KL; Trabert, B; Vitonis, A; Webb, PM; Wentzensen, N; Wu, AH; Ziogas, A, 2014) |
| "To determine the basic expression of ABC transporters in an epithelial ovarian cancer cell line, and to investigate whether low concentrations of acetaminophen and ibuprofen inhibited the growth of this cell line in vitro." | 3.81 | Gene expression profile of ABC transporters and cytotoxic effect of ibuprofen and acetaminophen in an epithelial ovarian cancer cell line in vitro. ( Cândido, EB; da Silva Filho, AL; de Melo, FP; Lima, RA; Piedade, JB; Silva, LM; Vidigal, PV, 2015) |
| "In pediatric palliative care, acetaminophen is also used as an adjuvant to opioid therapy for pain as well as an anti-pyretic." | 3.79 | Use of intravenous acetaminophen (paracetamol) in a pediatric patient at the end of life: case report. ( Keefer, P; Marks, AD; Saul, D, 2013) |
| "Pooling individual-level data from 12 Ovarian Cancer Association Consortium studies, we evaluated the association between self-reported, pre-diagnosis use of common analgesics and overall/progression-free/disease-specific survival among 7694 women with invasive epithelial ovarian cancer (4273 deaths)." | 2.55 | Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. ( Anton-Culver, H; Bandera, EV; Beeghly-Fadiel, A; Berchuck, A; Cramer, DW; deFazio, A; Dixon, SC; Doherty, JA; Edwards, RP; Gayther, SA; Gentry-Maharaj, A; Goodman, MT; Høgdall, E; Jensen, A; Kjær, SK; Menon, U; Modugno, F; Moysich, KB; Nagle, CM; Ness, RB; Paddock, LE; Pearce, CL; Pike, MC; Poole, EM; Ramus, SJ; Risch, HA; Rossing, MA; Schildkraut, JM; Terry, KL; Trabert, B; Webb, PM; Wentzensen, N; Wicklund, KG; Wu, AH; Ziogas, A, 2017) |
| "Aspirin use was associated with a reduced risk of ovarian cancer (OR = 0." | 2.50 | Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. ( Anton-Culver, H; Bandera, EV; Berchuck, A; Brinton, LA; Chandran, U; Cramer, DW; Doherty, JA; Gayther, SA; Gentry-Maharaj, A; Goode, EL; Goodman, MT; Hogdall, E; Jensen, A; Jordan, SJ; King, MG; Kjær, SK; Lo-Ciganic, WH; Lurie, G; Menon, U; Murphy, MA; Nagle, CM; Ness, RB; Olson, S; Pearce, CL; Pike, MC; Poole, EM; Ramus, SJ; Risch, HA; Rossing, MA; Schildkraut, JM; Terry, KL; Trabert, B; Vitonis, A; Webb, PM; Wentzensen, N; Wu, AH; Ziogas, A, 2014) |
| "Ovarian cancer is the leading cause of death from gynaecological malignancy, especially because of late diagnosis." | 2.44 | [Chemoprevention and prophylactic surgery in ovarian carcinoma]. ( Deffieux, X; Faivre, E; Fernandez, H; Frydman, R; Morice, P; Touboul, C; Uzan, C, 2007) |
| "Most women with ovarian cancer (OC) are diagnosed with advanced disease." | 1.91 | Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study. ( DeFazio, A; Friedlander, M; Grant, P; Jordan, SJ; Majidi, A; Na, R; Obermair, A; Webb, PM, 2023) |
| "The cases were all women in Denmark with epithelial ovarian cancer diagnosed during 2000-2009 (Paper 1) and 2000-2011 (Papers 2 and 3), identified in the Cancer Registry." | 1.42 | Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study. ( Baandrup, L, 2015) |
| "Ovarian cancer is commonly treated with cisplatin/paclitaxel but many tumors become resistant." | 1.39 | Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma. ( Muldoon, LL; Neuwelt, AJ; Neuwelt, EA; Wu, YJ, 2013) |
| "Risk reductions of ovarian cancer were observed with use of aspirin or selective cyclooxygenase-2 inhibitors." | 1.38 | Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. ( Bunker, CH; Edwards, RP; Lo-Ciganic, WH; Moysich, KB; Ness, RB; Zgibor, JC, 2012) |
| "We included 756 women with epithelial ovarian cancer and 1564 randomly selected control women aged 35-79 years." | 1.38 | Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study. ( Ammundsen, HB; Blaakaer, J; Faber, MT; Høgdall, C; Høgdall, E; Jensen, A; Kjaer, SK, 2012) |
| " The authors did not observe a dose-response relation with increased frequency or duration of regular use of any of these medications and ovarian cancer incidence." | 1.35 | Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts. ( Cramer, DW; Hankinson, SE; Pinheiro, SP; Rosner, BA; Tworoger, SS, 2009) |
| "Analgesic use may reduce ovarian cancer risk, possibly through antiinflammatory or antigonadotropic effects." | 1.35 | Analgesic drug use and risk of epithelial ovarian cancer. ( Cushing-Haugen, KL; Hannibal, CG; Rossing, MA; Wicklund, KG, 2008) |
| "In a prospective study, we evaluated ovarian cancer risk associated with self-reported use of medications that influence inflammation or gonadotropin levels." | 1.32 | Medication use and risk of ovarian carcinoma: a prospective study. ( Hartge, P; Lacey, JV; Schairer, C; Schatzkin, A; Sherman, ME, 2004) |
| "We compared 780 women with epithelial ovarian cancer to 2053 cancer controls and 2570 noncancer controls." | 1.31 | A case-control study of analgesic use and ovarian cancer. ( Coogan, PF; Palmer, JR; Rao, RS; Rosenberg, L; Shapiro, S; Stolley, PD; Strom, BL; Zauber, AG, 2000) |
| "Aspirin users were not at reduced risk of ovarian cancer compared with nonusers (adjusted OR, 1." | 1.31 | Regular use of analgesic drugs and ovarian cancer risk. ( Menezes, RJ; Mettlin, C; Moysich, KB; Natarajan, N; Piver, MS; Swede, H, 2001) |
| "Apoptosis was observed in primary ovarian cancer cell culture treated with COX-2 inhibitor." | 1.31 | Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents. ( Barnes, MN; Grizzle, WE; Myers, RB; Oelschlager, DK; Partridge, EE; Rodríguez-Burford, C; Talley, LI, 2002) |
| "Four hundred eighty-three women with ovarian cancer and 1877 women matched for age, years of medical history in computer record, general practice attended, and calendar time; 3706 women with breast cancer and 14,155 matched control subjects; and 635 women with colon cancer and 2434 matched control subjects." | 1.31 | Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. ( Jick, H; Meier, CR; Schmitz, S, 2002) |
| "The odds ratio for risk of ovarian cancer for aspirin use was 0." | 1.30 | Over-the-counter analgesics and risk of ovarian cancer. ( Bohlke, K; Cramer, DW; Greenberg, ER; Harlow, BL; Titus-Ernstoff, L; Welch, WR, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.03) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 14 (42.42) | 29.6817 |
| 2010's | 15 (45.45) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Majidi, A | 1 |
| Na, R | 1 |
| Jordan, SJ | 2 |
| DeFazio, A | 3 |
| Obermair, A | 1 |
| Friedlander, M | 1 |
| Grant, P | 1 |
| Webb, PM | 4 |
| Dixon, SC | 1 |
| Nagle, CM | 3 |
| Wentzensen, N | 2 |
| Trabert, B | 2 |
| Beeghly-Fadiel, A | 1 |
| Schildkraut, JM | 3 |
| Moysich, KB | 3 |
| Risch, HA | 2 |
| Rossing, MA | 3 |
| Doherty, JA | 2 |
| Wicklund, KG | 2 |
| Goodman, MT | 2 |
| Modugno, F | 1 |
| Ness, RB | 3 |
| Edwards, RP | 2 |
| Jensen, A | 3 |
| Kjær, SK | 2 |
| Høgdall, E | 2 |
| Berchuck, A | 3 |
| Cramer, DW | 4 |
| Terry, KL | 2 |
| Poole, EM | 2 |
| Bandera, EV | 2 |
| Paddock, LE | 1 |
| Anton-Culver, H | 2 |
| Ziogas, A | 2 |
| Menon, U | 2 |
| Gayther, SA | 2 |
| Ramus, SJ | 2 |
| Gentry-Maharaj, A | 2 |
| Pearce, CL | 2 |
| Wu, AH | 2 |
| Pike, MC | 2 |
| Wu, YJ | 1 |
| Neuwelt, AJ | 1 |
| Muldoon, LL | 1 |
| Neuwelt, EA | 1 |
| Tsoref, D | 1 |
| Panzarella, T | 1 |
| Oza, A | 1 |
| Lo-Ciganic, WH | 2 |
| Murphy, MA | 1 |
| Goode, EL | 1 |
| Brinton, LA | 1 |
| Lurie, G | 1 |
| Hogdall, E | 1 |
| Vitonis, A | 1 |
| Olson, S | 1 |
| King, MG | 1 |
| Chandran, U | 1 |
| Errico, A | 1 |
| Baandrup, L | 2 |
| Friis, S | 1 |
| Dehlendorff, C | 1 |
| Andersen, KK | 1 |
| Olsen, JH | 1 |
| Kjaer, SK | 2 |
| Ibiebele, TI | 1 |
| Protani, MM | 1 |
| Lheureux, S | 1 |
| Karakasis, K | 1 |
| Oza, AM | 1 |
| Lima, RA | 1 |
| Cândido, EB | 1 |
| de Melo, FP | 1 |
| Piedade, JB | 1 |
| Vidigal, PV | 1 |
| Silva, LM | 1 |
| da Silva Filho, AL | 1 |
| Pinheiro, SP | 1 |
| Tworoger, SS | 2 |
| Rosner, BA | 1 |
| Hankinson, SE | 2 |
| Gates, MA | 1 |
| Eliassen, AH | 1 |
| Missmer, SA | 1 |
| Samulak, D | 1 |
| Michalska, M | 1 |
| Gaca, M | 1 |
| Wilczak, M | 1 |
| Mojs, E | 1 |
| Chuchracki, M | 1 |
| Zgibor, JC | 1 |
| Bunker, CH | 1 |
| Ammundsen, HB | 1 |
| Faber, MT | 1 |
| Blaakaer, J | 1 |
| Høgdall, C | 1 |
| Marks, AD | 1 |
| Keefer, P | 1 |
| Saul, D | 1 |
| Rodríguez-Burford, C | 2 |
| Oelschlager, DK | 2 |
| Talley, LI | 2 |
| Barnes, MN | 2 |
| Partridge, EE | 2 |
| Grizzle, WE | 2 |
| Lacey, JV | 1 |
| Sherman, ME | 1 |
| Hartge, P | 1 |
| Schatzkin, A | 1 |
| Schairer, C | 1 |
| Altinoz, MA | 2 |
| Korkmaz, R | 1 |
| Moorman, PG | 1 |
| Halabi, S | 1 |
| Calingaert, B | 1 |
| Marks, JR | 1 |
| Crew, KD | 1 |
| Neugut, AI | 1 |
| Bonovas, S | 1 |
| Filioussi, K | 1 |
| Sitaras, NM | 1 |
| Deffieux, X | 1 |
| Touboul, C | 1 |
| Uzan, C | 1 |
| Faivre, E | 1 |
| Frydman, R | 1 |
| Fernandez, H | 1 |
| Morice, P | 1 |
| Hannibal, CG | 1 |
| Cushing-Haugen, KL | 1 |
| Harlow, BL | 1 |
| Titus-Ernstoff, L | 1 |
| Bohlke, K | 1 |
| Welch, WR | 1 |
| Greenberg, ER | 1 |
| Rodriguez, C | 1 |
| Henley, SJ | 1 |
| Calle, EE | 1 |
| Thun, MJ | 1 |
| Rosenberg, L | 1 |
| Palmer, JR | 1 |
| Rao, RS | 1 |
| Coogan, PF | 1 |
| Strom, BL | 1 |
| Zauber, AG | 1 |
| Stolley, PD | 1 |
| Shapiro, S | 1 |
| Mettlin, C | 1 |
| Piver, MS | 1 |
| Natarajan, N | 1 |
| Menezes, RJ | 1 |
| Swede, H | 1 |
| Myers, RB | 1 |
| Meier, CR | 1 |
| Schmitz, S | 1 |
| Jick, H | 1 |
| Bilir, A | 1 |
| Attar, E | 1 |
| Erkan, M | 1 |
| Aydiner, A | 1 |
| Chen, JT | 1 |
| Hirai, Y | 1 |
| Yagi, H | 1 |
| Katase, K | 1 |
| Shimizu, Y | 1 |
| Nakayama, K | 1 |
| Teshima, H | 1 |
| Hamada, T | 1 |
| Fujimoto, I | 1 |
| Yamuchi, K | 1 |
6 reviews available for acetaminophen and Ovarian Neoplasms
| Article | Year |
|---|---|
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
Topics: Acetaminophen; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Ag | 2017 |
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Australia; | 2014 |
NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Cyclooxygenase 2; C | 2004 |
Aspirin and NSAIDs: effects in breast and ovarian cancers.
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Femal | 2006 |
Paracetamol use and risk of ovarian cancer: a meta-analysis.
Topics: Acetaminophen; Antineoplastic Agents; Case-Control Studies; Cohort Studies; Female; Humans; Ovarian | 2006 |
[Chemoprevention and prophylactic surgery in ovarian carcinoma].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Carcinoma; Chemoprevention; Contraceptives, Oral; Evidence- | 2007 |
2 trials available for acetaminophen and Ovarian Neoplasms
| Article | Year |
|---|---|
Efficiency of postoperative pain management after gynecologic oncological surgeries with the use of morphine + acetaminophen + ketoprofen versus morphine + metamizol + ketoprofen.
Topics: Acetaminophen; Analgesics; Carcinoma; Dipyrone; Drug Therapy, Combination; Endometrial Neoplasms; Fe | 2011 |
[Effect of medical vagotomy on the CDDP induced nausea and vomiting evaluated by the chemotherapy-vomiting time (CV time)].
Topics: Acetaminophen; Adult; Cisplatin; Female; Humans; Metoclopramide; Middle Aged; Nausea; Ovarian Neopla | 1988 |
25 other studies available for acetaminophen and Ovarian Neoplasms
| Article | Year |
|---|---|
Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study.
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Australia; Female; Huma | 2023 |
Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma.
Topics: Acetaminophen; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apopt | 2013 |
Aspirin in prevention of ovarian cancer: are we at the tipping point?
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Carcinoma, | 2014 |
Prevention: daily aspirin and chemoprevention.
Topics: Acetaminophen; Adenomatous Polyposis Coli; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticar | 2014 |
Prescription use of paracetamol and risk for ovarian cancer in Denmark.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carci | 2014 |
Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Middle Aged; | 2015 |
Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Topics: Academic Dissertations as Topic; Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narc | 2015 |
How to assess the potential interest of aspirin in ovarian cancer?
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Ovarian Neoplasms | 2015 |
Gene expression profile of ABC transporters and cytotoxic effect of ibuprofen and acetaminophen in an epithelial ovarian cancer cell line in vitro.
Topics: Acetaminophen; ATP-Binding Cassette Transporters; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; C | 2015 |
Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.
Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Follow-Up Studies; H | 2009 |
Analgesic use and sex steroid hormone concentrations in postmenopausal women.
Topics: Acetaminophen; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; E | 2010 |
Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Chi-Square Di | 2012 |
Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.
Topics: Acetaminophen; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Ag | 2012 |
Use of intravenous acetaminophen (paracetamol) in a pediatric patient at the end of life: case report.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Child; Fatal Outcome; Female; Humans; Injections, Intraveno | 2013 |
The use of dimethylsulfoxide as a vehicle in cell culture experiments using ovarian carcinoma cell lines.
Topics: Acetaminophen; Aspirin; Cell Count; Cell Culture Techniques; Cell Division; Cell Line, Tumor; Cultur | 2003 |
Medication use and risk of ovarian carcinoma: a prospective study.
Topics: Acetaminophen; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Stu | 2004 |
Analgesic drug use and risk of ovarian cancer.
Topics: Acetaminophen; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Confoundi | 2006 |
Analgesic drug use and risk of epithelial ovarian cancer.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2008 |
Over-the-counter analgesics and risk of ovarian cancer.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 1998 |
Paracetamol and risk of ovarian cancer mortality in a prospective study of women in the USA.
Topics: Acetaminophen; Animals; Female; Humans; Mice; Ovarian Neoplasms; Proportional Hazards Models; Prospe | 1998 |
A case-control study of analgesic use and ovarian cancer.
Topics: Acetaminophen; Adult; Age Factors; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ste | 2000 |
Regular use of analgesic drugs and ovarian cancer risk.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cas | 2001 |
Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Biopsy; Blotting, Wester | 2002 |
Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer.
Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Breast | 2002 |
Acetaminophen modulations of chemotherapy efficacy in MDAH 2774 human endometrioid ovarian cancer cells in vitro.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carboplatin; Cell Div | 2002 |